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OBJECTIVE To determine predictors of systolic anterior motion and left ventricular outflow tract
obstruction (SAM/LVOTO) after mitral valve repair (MVRep) in patients with myxomatous
mitral valve disease.
BACKGROUND Mechanisms for the development of SAM/LVOTO after MVRep have been described;
however, predictors of this complication have not been explored. We hypothesize that
pre-MVRep transesophageal echocardiography (TEE) can predict postrepair SAM/
LVOTO.
METHODS Using TEE, the lengths of the coapted anterior (AL) and posterior (PL) leaflets and the
distance from the coaptation point to the septum (C-Sept) were measured before and after
MVRep in 33 patients, including 11 who developed SAM/LVOTO (Group 1) and 22 who
did not (Group 2).
RESULTS Group 1 patients had smaller AL/PL ratios (0.99 vs. 1.95, p , 0.0001) and C-Sept distances
(2.53 vs. 3.01 cm, p 5 0.012) prior to MVRep than those in Group 2. Resolution of
SAM/LVOTO was associated with increases in AL/PL ratio and C-Sept distance. This
reflects a more anterior position of the coaptation point in those who developed SAM/
LVOTO.
CONCLUSIONS These data suggest that TEE analysis of the mitral apparatus can identify patients likely to
develop SAM/LVOTO after MVRep for myxomatous valve disease. The findings are
consistent with the concept that SAM of mitral leaflets is due to anterior malposition of slack
mitral leaflet portions into the LVOT. The position of the coaptation point of the mitral
leaflets is dynamic and a potential target and end point for surgical designs to prevent
SAM/LVOTO post MVRep. (J Am Coll Cardiol 1999;34:2096–104) © 1999 by the
American College of Cardiology
Systolic anterior motion of the mitral valve and left ventric-
ular outflow tract obstruction has been described after mitral
valve repair (MVRep) in patients with myxomatous mitral
valve disease (1–8). The incidence ranges from 2% to 16%,
despite recent advances in MVRep (1,5,9).
It has been suggested that systolic anterior motion of the
mitral leaflets (SAM) and left ventricular outflow tract
obstruction (LVOTO) may not be entirely or primarily due
to the Venturi effect (10–12). Studies have related SAM to
abnormalities of the mitral valve apparatus itself (5,10,12–
15). Contributing factors include the position of papillary
muscles and mitral leaflet anatomy (10,12,13,15). Anteri-
orly displaced papillary muscles malposition the mitral valve
toward the left ventricular outflow tract, increasing the
likelihood of SAM and LVOTO (5). This increased risk
may be due to changes in direction of ventricular flows and
the presence of mitral tissue in the outflow tract, making it
more susceptible to systolic outflow (10,12,13,15). Other
causes include abnormalities of the mitral leaflets (5,14). In
particular, a relatively large posterior leaflet may coapt with
the anterior leaflet closer to its base and cause both an
anterior shift of the coaptation point, and an increase in the
amount of slack leaflet tissue in the outflow tract (5,14). The
residual leaflet portion beyond the coaptation point, unlike
the coapted portions that are held in place by the transmitral
pressure difference, are relatively free to move in response to
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flow-related forces in the LVOT (16). Elongation of the
anterior leaflet may cause a similar increase in the relatively
slack residual leaflet. Both of these conditions make the
leaflets more susceptible to the effects of systolic outflow
(14). In vitro analysis has shown that increases in both
anterior and posterior leaflet positions can predispose to
systolic anterior motion (14). Proposed mechanisms for
SAM postmitral valve repair have therefore incorporated
the concept that the leaflet anatomy and position contribute
to systolic anterior motion (5,6).
The purpose of this study was to explore prerepair
echocardiographic predictors of SAM and LVOTO after
MVRep. We hypothesized that prerepair transesophageal
echocardiographic (TEE) evaluation has the potential to
predict the development of systolic anterior motion of the
mitral leaflets and LVOTO after cardiopulmonary bypass in
patients undergoing MVRep for myxomatous valve disease
based on features of the mitral apparatus that would
predispose to SAM. This predictive information could
potentially allow tailoring of the surgical approach to valve
repair designed to limit or avoid this complication.
METHODS
Patient selection. We studied a total of 33 patients who
were undergoing TEE evaluation before MVRep for myx-
omatous mitral valve disease with prolapse, as defined by
Perloff et al. (17). According to the database, the overall
incidence of SAM/LVOTO after repair in this patient
population was approximately 5%. These included 11 con-
secutive patients who developed SAM and LVOTO after
MVRep (Group 1) and 22 consecutive patients in whom
this did not occur (Group 2). These were not 33 consecutive
MVRep cases.
Table 1 shows demographic data including age, gender,
surgical procedure, valve morphology and pre- and postcar-
diopulmonary fractional shortening. Fractional shortening
was measured using the following formula:
~LVIDd 2 LVIDs!/LVIDd
Image acquisition and measurement. Intraoperative TEE
studies were performed in standard views, particularly lon-
gitudinal views of the left heart from the left atrial window,
using a Hewlett-Packard phased array sector scanner. Stud-
ies were reviewed and measured by two examiners (A.D.M.
and J.M.H.). One examiner was aware of the presence of
SAM after repair (A.D.M.) and the second (J.M.H.) was
not. Clinically and hemodynamically important systolic
anterior motion, as defined by Grigg et al. using two-
dimensional and color Doppler, was said to be present if
there was:
1) two-dimensional visualization of systolic anterior motion
into the left ventricular outflow tract, and
2) a mosaic pattern by color Doppler seen in the left
ventricular outflow tract, suggesting increased velocities
and disturbed or turbulent flow and in the left atrium,
consistent with mitral regurgitation (18). Measurements
were made pre- and postcardiopulmonary bypass in
Groups 1 and 2, as well as after resolution of SAM/
LVOTO in Group 1. Each examiner made each mea-
surement three times from three cardiac cycles. Mea-
surements from both examiners were averaged.
Measurements were made from the transverse five-chamber
view, as reported by Lee et al. (5). Visualization of mitral
Abbreviations and Acronyms
AL 5 anterior leaflet length to mitral valve
contribution (annulus to coaptation)
Ann Diam 5 mitral valve annulus diameter
C-Ann 5 distance from the coaptation point to the
mitral annular plane
Coapt-Ann 5 coaptation point to the mitral annulus
C-Sept 5 distance from septum to mitral valve
coaptation point
HCM 5 hypertrophic cardiomyopathy
HOCM 5 hypertrophic obstructive cardiomyopathy
LVIDs(d) 5 left ventricular internal diameter in
systole (diastole)
LVOTO 5 left ventricular outflow tract obstruction
MVRep 5 mitral valve repair
PL 5 posterior leaflet length to mitral valve
contribution (annulus to coaptation)
SAM 5 systolic anterior motion of the mitral
leaflet(s)
TEE 5 transesophageal echocardiography,
echocardiographic
Table 1. Demographics of Study Patients
SAM/LVOTO
(11)
no SAM/LVOTO
(22)
Age 62 65
Gender (M/F) 7/4 12/10
Surgical procedure
Mitral valve repair 9 17
CABG/MVRepair 2 5
Valve repair
Post leaflet resection 11 22
Rigid ring 8 15
Flexible ring 3 7
Valve leaflet pathology
Postprolapse 9 15
Anter prolapse 1 3
Combined prolapse 1 4
Flail posterior 1 1
Pre-CPB shortening 0.51 0.52
Post-CPB shortening 47 0.51
CPB wean
Inotropes 4 9
Pressors 4 9
Anter 5 anterior; CABG/MVR 5 coronary artery bypass graft/mitral valve repair;
CPB 5 cardiopulmonary bypass; LVOTO 5 left ventricular outflow tract obstruc-
tion; Post 5 posterior; SAM 5 systolic anterior motion.
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valve coaptation and the left ventricular outflow tract can be
consistently obtained in this view (Fig. 1). In order to
evaluate the geometry of the mitral valve and its relation to
the left ventricular outflow tract and ventricular cavity, all
measurements were made at the onset of ventricular ejec-
tion. As shown in Figure 1, we measured the lengths of the
coapted anterior (AL) and posterior (PL) leaflets (annulus
to coaptation for each leaflet) to explore the contribution of
each leaflet to coaptation, the minimum distance from the
coaptation point to the septum (C-Sept), the diameter of
the mitral valve annulus (Ann Diam) and the length of the
residual anterior leaflet portion beyond the coaptation point.
All diameter measurements were made using leading edge
to leading edge. After placement of the annulus, the annular
diameter was made from the inner aspects of the ring. The
LVID was measured at the same time in systole in the same
view (LVIDs). As shown in Figure 1, the diameter of the
LV was measured at the base of the heart instead of the
midventricular level. This was done for two reasons. The
first was because this was the more consistently obtained
site. The second, and more important reason, was to
measure the dimension at the site most likely to contribute
to SAM/LVOTO. The perpendicular axial distance from
the coaptation point to the mitral annulus (Coapt-Ann) was
also measured to express how far leaflet coaptation is
positioned into the left ventricle.
During SAM the measured anterior leaflet length was the
straight distance from the anterior annulus to the site of
coaptation. The C-Sept distance was measured as the
minimum distance from the coaptation to the septum.
In cases of flail leaflet a series of cardiac cycles was
obtained for each measurement. Scrolling through the cycle
allowed the examiners to estimate where the leaflets may
have coapted during systole. This spot was taken as the site
of coaptation and subsequent measurements were made
using this reference.
Statistical analysis. Mean, standard deviation and range of
data points are presented in Table 2. Prerepair measure-
ments were compared between Group 1 and Group 2
patients using Student two-sample t tests; the correspond-
ing p values are also reported. Because we are examining
multiple end points, we consider p , 0.01 as statistically
significant.
If for any measurement there was no overlap of the ranges
of values of the two groups so that whether or not the
subject developed SAM/LVOTO was perfectly predicted
by the measurements, we calculated 95% tolerance intervals (or
prediction intervals for a future observation). While the range
represents the limits of the observed sample values, the 95%
tolerance interval represents the expected limits of 95% of the
corresponding population values; that is, the interval is ex-
pected to enclose at least 95% of the population values.
As a secondary analysis, the groups were compared with
respect to their measurements after repair to examine
whether differences between the groups persisted and how
the measurements changed from pre- to postrepair. This
was done to identify possible mechanisms of SAM/LVOTO,
as was done in a previous study (5). Measurements after repair
were compared between groups using two-sample t tests. The
corresponding p values are also reported in Table 2. Changes
between pre- and postrepair were compared using paired t
test, separately, for each group for simplicity; the general
significance levels were denoted in Table 2 using symbols.
Because of the multiplicity of testing for each measurement,
we considered p , 0.01 as statistically significant.
Interobserver variability was assessed for prerepair mea-
sures using bias analysis. The differences between measure-
ments made by two independent examiners were divided by
the means and multiplied by 100%. The results were
averaged to give a mean bias reported as a percent difference.
RESULTS
A total of 33 patients were studied in the two groups; they
did not have significant differences in age, gender, pre- and
postrepair fractional shortening, anterior versus posterior
leaflet involvement in prolapse, surgical procedure or use of
vasoactive drugs to facilitate separation from cardiopulmo-
Figure 1. Schematic demonstrating the transesophageal echocar-
diographic measurements performed prior to and after mitral valve
repair. The image was obtained from the esophageal location at
zero degrees (horizontal) plane. Structures included the left atrium,
left ventricle, mitral valve and the left ventricular outflow tract.
Lengths of the anterior and posterior leaflets were obtained using
the central scallops.
AL 5 anterior leaflet length; Ann Diam 5 annular diameter;
CoaptAnn 5 distance from the mitral coaptation point to the
annular plane; CSept 5 distance from the mitral coaptation point
to the septum; LVIDs 5 left ventricular internal diameter in
systole; PL 5 posterior leaflet length.
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nary bypass (Table 1). All patients in both groups under-
went mitral valve ring annuloplasty and quandrangular
resection of the posterior leaflet with no surgical procedure
performed on the anterior leaflet.
Precardiopulmonary bypass data (Table 2). Precardio-
pulmonary bypass data showed a significant difference
between Groups 1 and 2 with respect to the contribution of
the valve leaflets to coaptation. The position of the coapta-
tion point (C-Sept distance) tended to lie closer to the
LVOT in Group 1 (p 5 0.012). Group 1 patients had a
smaller AL/PL ratio (0.99 vs. 1.95; p 5 0.0001) and C-Sept
distance (2.53 cm vs. 3.01 cm; p 5 0.012) compared with
Group 2. Group 1 patients had a larger PL (2.18 cm vs.
1.42 cm; p , 0.0001) and smaller AL (2.13 cm vs. 2.68 cm;
p 5 0.0004). There was no overlap in the prerepair ratio of
coapted anterior to posterior leaflet length between those
who developed SAM/LVOTO (0.75–1.17) and those who
did not (1.33–2.80), reflecting a more anterior position of
coaptation in those who developed SAM. The correspond-
ing 95% tolerance intervals indicate that we would expect at
least 95% of patients who develop SAM/LVOTO to have
AL/PL ratios between 0.66 and 1.32 and at least 95% of
patients who do not to have AL/PL ratios between 1.01 and
2.89, suggesting that there is limited overlap in the popu-
lations also. Figures 2 and 3 demonstrate images of patients
from Groups 1 and 2.
Changes in echocardiographic measurements from be-
fore to immediately after cardiopulmonary bypass (Table
2). Both groups showed decreases in the lengths of the
coapted anterior and posterior leaflet portions, annular
diameters and C-Sept distance from before to after bypass
with increases in the amount of residual leaflet measured
beyond the coaptation point. Group 2 patients showed a
decrease in LVIDs, while Group 1 patients showed little
change. The AL/PL ratio in Group 2 patients increased by
nearly 60% (relative posterior shift in the coaptation point),
while this measurement stayed essentially unchanged in
Group 1.
Postcardiopulmonary bypass measurements (Table 2).
Postcardiopulmonary bypass measurements showed that
differences between Group 1 and Group 2 persisted. Group
1 continued to have smaller AL/PL ratios (1.14 vs. 3.08),
smaller C-Sept distances (1.90 cm vs. 2.52 cm) and greater
residual leaflet (1.61 cm vs. 0.68 cm) than Group 2. Group
1 patients also had a greater distance from the coaptation
point to the annulus in the immediate postbypass period
(0.84 cm vs. 0.47 cm) with a tendency for an increase in this
distance immediately after repair compared with a decrease
in Group 2.
Of the 11 patients in whom SAM and LVOTO was
seen, four had complete resolution of LVOTO and mitral
regurgitation after weaning inotropes, fluid administration
and, in one patient, administration of esmolol. With reso-
lution of SAM, these four patients showed increases in
AL/PL ratio and C-Sept distance with a decrease in the
length of the residual tissue beyond the coaptation point
(Table 3). The coaptation point to the mitral annulus
(Coapt-Ann) also decreased with resolution of SAM.
Of the 11 patients with SAM, 7 still had SAM after
pharmacologic and fluid therapy, four without color Dopp-
Table 2. Pre- and Immediately Post-Cardiopulmonary Bypass Echocardiographic Measurements
Pre-CPB Immediately Post-CPB
I: SAM/LVOTO
(11) p Value
II: No SAM/LVOTO
(22)
I: SAM/LVOTO
(11) p Value
II: No SAM/LVOTO
(22)
AL (cm) 2.13 (0.34) 0.0004 2.68 (0.39) 1.36 (0.28)* 0.002 1.83 (0.42)*
(1.53–2.72) (1.98–3.35) (0.98–2.05) (1.00–2.71)
PL (cm) 2.18 (0.37) , 0.0001 1.42 (0.27) 1.23 (0.27)* 0.0001 0.61 (0.10)*
(1.68–2.79) (0.86–1.89) (0.84–1.82) (0.37–0.76)
AL/PL 0.99 (0.14) 0.0001 1.95 (0.45) 1.14 (0.27) 0.0001 3.08 (0.87)*
(0.75–1.17) (1.33–2.80) (0.80–1.83) (1.86–5.39)
Residual leaf length (cm) 0.52 (0.62) . 0.05 0.27 (0.29) 1.61 (0.31)* , 0.001 0.68 (0.33)*
(0.00–1.76) (0.00–0.77) (1.21–2.08) (0.00–1.18)
C-Sept (cm) 2.53 (0.34) 0.012 3.01 (0.56) 1.90 (0.30)* 0.0004 2.52 (0.47)*
(2.05–3.12) (2.05–3.95) (1.47–2.43) (1.89–3.81)
Ann Diam (cm) 3.93 (0.74) . 0.05 3.83 (0.43) 2.04 (0.46)* . 0.05 2.18 (0.48)*
(2.91–5.18) (2.89–4.60) (1.60–3.25) (1.20–3.30)
Coapt Ann (cm) 0.63 (0.26) . 0.05 0.62 (0.29) 0.84 (0.19) , 0.001 0.47 (0.12)*
(0.07–0.98) (0.13–1.38) (0.40–1.08) (0.30–0.65)
LVIDs (cm) 3.56 (0.60) 0.044 4.18 (0.88) 3.44 (0.48) . 0.05 3.26 (0.48)*
(2.55–4.4) (2.75–5.62) (2.60–4.02) (2.40–3.98)
Data are presented as mean (standard deviation) and range of values.
Ann Diam 5 annular diameter; AL 5 anterior leaflet length; Coapt Ann 5 distance from coaptation point to annulus; C-Sept 5 distance from the mitral coaptation point
to the septum; LVIDs 5 left ventricular internal diameter in systole; PL 5 posterior leaflet length; Residual leaf 5 amount of leaflet beyond the mitral coaptation point.
*p # 0.001 compared with pre-CPB measurement.
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ler evidence of LVOTO and mitral regurgitation. The three
patients with clinically significant SAM were compared
with the eight without residual LVOTO or moderate mitral
regurgitation (Table 4). Although all of these patients had a
relatively anterior position of coaptation (low AL/PL)
prerepair, those with persistent outflow tract obstruction
had larger anterior and posterior leaflet lengths (AL: 2.46
vs. 2.01 cm, PL: 2.45 vs. 2.08 cm), providing increased
leaflet tissue available for SAM.
Interobserver variability was 4.4% on average for all
prerepair measurements (Table 5) with a mean difference of
0.03 cm.
DISCUSSION
Results. We have demonstrated that echocardiographic
evaluation of the mitral valve may predict development of
SAM/LVOTO in patients with myxomatous disease un-
dergoing MVRep. Relatively greater contribution of the
posterior leaflet (lower AL/PL) to the coaptation of the
mitral valve prior to repair was uniformly found in patients
who exhibited SAM/LVOTO after repair. Also, those
patients with SAM/LVOTO (Group 1) tended to have a
smaller prerepair C-Sept compared with those without
(Group 2). These differences persisted after repair during
SAM/LVOTO.
In four Group 1 patients, resolution of postrepair systolic
anterior motion was associated with a decrease in PL,
increased AL/PL, increased C-Sept, reduction in residual
leaflet and movement of the coaptation point posteriorly
and closer to the annular plane.
Three Group 1 patients with longer anterior mitral
leaflets prior to repair and a greater reduction in annular
diameter after repair were likely to show color Doppler
Figure 2. Echocardiographic image of a Group 2 patient. The top
image represents premitral valve repair and the bottom image
represents postvalve repair.
Figure 3. Echocardiographic image of a Group 1 patient. The top
image represents premitral valve repair; the middle image shows
systolic anterior motion of the anterior mitral leaflet and left
ventricular outflow tract obstruction (SAM/LVOTO) and the
bottom image represents resolution of the SAM/LVOTO. Res-
olution occurred after discontinuation of inotropes, administration
of intravenous fluid, vasopressor and beta-blocker (esmolol).
LVOTO 5 left ventricular outflow tract obstruction; SAM 5
systolic anterior motion of the mitral leaflet.
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evidence of outflow tract obstruction despite treatment with
intravenous fluid, vasopressors and discontinuation of ino-
tropes.
Mechanism. These data demonstrate that the posterior
and anterior leaflet contribution to valve closure and posi-
tion of the coaptation point contribute to SAM of the mitral
leaflets. The larger posterior leaflet coapts with the anterior
leaflet closer to its base resulting in increased residual or
“slack” leaflet portions which lie closer to the outflow tract
and are thus more susceptible to systolic outflow.
In Group 1 the postrepair AL/PL ratio was less than 1.2
despite a posterior leaflet plication. Anterior leaflet length
decreased, while leaflet beyond the coaptation point in-
creased. The reduction in AL is probably due to coaptation
toward its base with a relatively large PL and reduction in
annular diameter. In addition, the distance from the coap-
tation point to the mitral annular plane (C-Ann) in Group
1 increased compared with Group 2. This resulted in
increased slack leaflet and coaptation close to the left
ventricular outflow tract and further into the left ventricular
cavity (shorter C-Sept and larger C-Ann). Such changes in
coaptation increase the likelihood of SAM/LVOTO.
Relation to literature. This is the first study to investigate
echocardiographic predictors of SAM and LVOTO in this
population. There have been studies examining the mech-
anism of SAM after MVRep. Lee et al. also demonstrated
an increase in posterior leaflet length (posterior annulus to
coaptation point) and a smaller C-Sept distance in the
period after bypass in patients with SAM and LVOTO (5).
C-Sept distances prior to repair and during SAM were
similar in the two studies (2.6 cm and 1.7 cm, respectively,
in Lee et al. and 2.5 cm and 1.9 cm in our study). Also,
prerepair posterior leaflet length in Lee’s study was 1.9 cm
compared with 2.2 cm in our study. As in our study,
resolution was associated with decreased posterior leaflet
contribution to coaptation and an increased C-Sept distance
(2.3 cm in Lee et al. vs. 2.4 cm above). These changes
occurred after partial or complete removal of the annulo-
plasty resulting in complete resolution in 7 of 14 patients
and significant improvement in the other 7. The authors
concluded that “an annuloplasty of any kind can displace the
valve coaptation into the left ventricle.”
In several experimental models, alterations in the mitral
apparatus caused SAM and LVOTO (10,12–15). Cape et
al. used an in vitro flow chamber to demonstrate that
anterior and inward displacement of the papillary muscle
altered chordal tension resulting in residual leaflets and
systolic anterior motion (10). Levine et al. demonstrated
that anterior displacement of the papillary muscles shifted
the mitral coaptation point toward the base of the leaflets,
resulting in systolic anterior motion (12). Lefebvre et al.
demonstrated that anteriorly placed papillary muscles re-
sulted in systolic anterior motion in the absence of hyper-
trophy (15). However, with a posterior placed papillary
muscle, no systolic anterior motion was seen despite severe
septal hypertrophy and flow velocities of 3.3 m/s. Using an
in vitro pulsatile flow model, Lefebvre et al. showed that
displacement of papillary muscle affected ventricular flow
direction (13). With normal papillary muscle position,
systolic outflow was proximate to the septum and exerted
minimal forces on the mitral leaflets. However, anterior
placement of the papillary muscle with subsequent move-
ment of the mitral apparatus toward the left ventricular
outflow tract altered ventricular flows such that systolic
flows were proximate to the posterior wall, impacting on the
mitral leaflets and resulting in systolic anterior motion.
Table 3. Pre-MVRep, Immediately Post-MVRep and Final
Echocardiographic Measurements of Four Group 1 Patients in
Which the Final TEE Exam Showed Resolution of Both SAM
and LVOTO
Post-CPB
Measurements
Pre-CPB
(4)
During
SAM (4)
Resolved
(4)
AL (cm) 2.03 (0.19) 1.19 (0.09) 1.59 (0.13)**
PL (cm) 2.33 (0.11) 1.24 (0.07) 0.96 (0.32)
AL/PL 0.86 (0.05) 0.96 (0.08) 1.78 (0.56)*
Residual leaflet
length (cm)
0.35 (0.35) 1.50 (0.17) 0.82 (0.51)**
C-Sept (cm) 2.40 (0.18) 1.63 (0.07) 2.37 (0.32)**
Ann Diam (cm) 3.95 (0.31) 1.92 (0.08) 2.16 (0.47)
Coapt Ann (cm) 0.68 (0.14) 0.89 (0.07) 0.47 (0.24)*
LVIDs (cm) 3.38 (0.32) 3.17 (0.17) 3.30 (0.44)
Statistical analysis compared changes from the immediate post-CPB measurements
(during SAM) to the final TEE exam (resolved). Data are presented as mean
(standard deviation).
Ann Diam 5 annular diameter; AL 5 anterior leaflet length; Coapt Ann 5
distance from coaptation point to annulus; C-Sept 5 distance from the mitral
coaptation point to the septum; LVIDs 5 left ventricular internal diameter in systole;
PL 5 posterior leaflet length; Residual leaf 5 amount of leaflet beyond the mitral
coaptation point.
*p , 0.05; **p , 0.01 compared with the time in which SAM was present.
Table 4. Precardiopulmonary Measurements of Patients in
Group 1
No LVOTO
(8)
LVOTO
(3)
AL (cm) 2.01 (0.10) 2.46 (0.14)*
PL (cm) 2.08 (0.11) 2.45 (0.24)
AL/PL 0.98 (0.05) 1.02 (0.08)
Residual leaflet length (cm) 0.44 (0.26) 0.71 (0.11)
C-Sept (cm) 2.45 (0.11) 2.72 (0.26)
Ann Diam (cm) 3.67 (0.21) 4.65 (0.39)*
Coapt Ann (cm) 0.65 (0.09) 0.58 (0.26)
LVIDs (cm) 3.60 (0.21) 3.44 (0.43)
The patients are grouped according to the final echo result. Those who had no
SAM/LVOTO or who had SAM without evidence of LVOTO or mitral regurgi-
tation (mild or less) are grouped together (no LVOTO) and compared with those
patients who had SAM/LVOTO and moderate or greater mitral regurgitation. Data
are presented as mean (standard deviation).
Ann Diam 5 annular diameter; AL 5 anterior leaflet length; Coapt Ann 5
distance from coaptation point to annulus; C-Sept 5 distance from the mitral
coaptation point to the septum; LVIDs 5 left ventricular internal diameter in systole;
PL 5 posterior leaflet length; Residual leaf 5 amount of leaflet beyond the mitral
coaptation point.
*p , 0.05 compared with the eight patients without LVOTO.
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He et al. (14), using a similar in vitro pulsatile flow
model, demonstrated that leaflet elongation favored SAM
by creating long overlapping residual leaflets capable of
moving anteriorly. In addition, posterior leaflet elongation
favored SAM by shifting leaflet coaptation anteriorly. Re-
sidual leaflet length correlated with the degree of SAM.
With the findings of this study and those of Lee et al., it
should be expected that the “sliding leaflet technique,” in
addition to a quadrangular resection, proposed by Jebara et
al., should reduce the incidence of SAM and LVOTO (1,5).
By decreasing the size of the posterior mitral leaflet,
coaptation will occur closer to the tip of the anterior leaflet
and more posteriorly in the ventricular cavity, leaving less
mitral tissue near the left ventricular outflow tract.
Reed et al. (19) presented two patients with SAM/
LVOTO after mitral valve repair who were treated with
transaortic resection of redundant anterior leaflet. Anterior
leaflet plication has subsequently been suggested by Grossi
et al. who demonstrated a reduction in SAM/LVOTO
when used in addition to posterior leaflet surgery (20,21).
A closer inspection of data presented by Jiang et al. (11)
demonstrates that lengths of the coapted anterior and
posterior leaflets and the AL/PL ratio in patients with
hypertrophic obstructive cardiomyopathy (HOCM) and
systolic anterior motion were similar to our Group 1
patients before and during SAM/LVOTO (HOCM; AL
1.8 cm, PL 1.9 cm, AL/PL 1.0 vs. Group 1 [prerepair]; AL
2.1, PL 2.2, AL/PL 1.0 and Group 1 [during SAM] AL
1.4 cm, PL 1.2 cm, AL/PL 1.1). Measurements of AL/PL
in both normal patients and patients with nonobstructive
hypertrophic cardiomyopathy (HCM) in Jiang et al. (11)
were similar to Group 2 patients (2.0, 2.3 and 2.0, respec-
tively). These comparisons suggest that defined and mea-
surably similar leaflet contributions to coaptation are asso-
ciated with SAM across different populations.
In other studies of patients with HOCM, AL/PL ratios
were similar to our Group 2 patients (22,23). These results
suggest that a long or redundant anterior leaflet increased
the risk of systolic anterior motion. Methodological differ-
ences may account for these findings, as mitral leaflet
measurements were made during diastole or from pathology
specimens with the leaflets spread out to maximum dimen-
sions. In contrast, we measured mitral dimensions during
systole to assess the functional or physiological dimensions
during this critical phase in the cardiac cycle. These studies
do, however, suggest that a large anterior leaflet contributes
to SAM. This was also suggested in Group 1 patients in
which SAM/LVOTO persisted despite medical treatment.
Kofflard et al. (24) performed myomectomy with anterior
leaflet extension using a gluteraldehyde preserved autolo-
gous pericardial patch. The patch was used to “stiffen” the
anterior leaflet thus reducing leaflet laxity (24,25). These
patients were favorably compared with 12 patients under-
going myomectomy alone. Eliminating this laxity of the
anterior leaflet may decrease the effects of systolic outflow
on the leaflets and reduce anterior motion and outflow tract
obstruction. Anterior leaflet plication, with or without
myomectomy, has also been reported by McIntosh et al.
(26) in patients with HOCM. These studies support the
idea that abnormalities of the mitral valve contribute sig-
nificantly to outflow tract obstruction and may be the ideal
target for surgical treatment of HOCM (24,26).
Implications. The results presented in this article, along
with a growing body of literature, emphasize the importance
of the mitral valve apparatus as a cause of SAM/LVOTO.
Simple precardiopulmonary bypass mitral valve measure-
ments, as presented above, may help guide surgical repair
and prevent SAM/LVOTO. While the length of the PL
and position of coaptation are important targets, the length
of the anterior leaflet, the AL/PL ratio and perhaps the
amount of tissue beyond the coaptation point are important
as well.
Study limitations. Data gathered retrospectively may be
flawed. However, given the consistency with other studies
and the growing literature relating the mitral apparatus to
SAM/LVOTO, we feel that our results will be confirmed in
future prospective studies (5,14).
Table 5. Interobserver Variability for PreCardiopulmonary Bypass Measurements
Pre CPB Group I Pre CPB Group II
Examiner
1
Examiner
2
Examiner
1
Examiner
2
AL (cm) 2.10 2.16 2.61 2.74
PL (cm) 2.21 2.14 1.35 1.39
AL/PL 0.95 1.01 1.93 1.97
Residual leaf length (cm) 0.49 0.55 0.27 0.26
C-Sept (cm) 2.48 2.57 2.95 3.07
Ann Diam (cm) 4.00 3.86 3.90 3.76
Coapt Ann (cm) 0.67 0.59 0.64 0.60
LVIDs (cm) 3.52 3.60 4.07 4.29
Ann Diam 5 annular diameter; AL 5 anterior leaflet length; Coapt Ann 5 distance from coaptation point to annulus; C-Sept 5
distance from the mitral coaptation point to the septum; LVIDs 5 left ventricular internal diameter in systole; PL 5 posterior
leaflet length; Residual leaf 5 amount of leaflet beyond the mitral coaptation point. Data are presented as the mean of each
examiner.
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In review of the data, there is a question of whether the
Group 1 and Group 2 patients had similar procedures.
Given that the repairs were done by different surgeons, it is
likely that there were variations. In Group 1, there was
approximately a 44% reduction in posterior leaflet height or
0.95 cm. In Group 2 there was a 57% reduction in posterior
leaflet height or 0.81 cm. Although the percent reduction
was greater in Group 2, the amount of posterior leaflet
resected appears to have been greater in Group 1. It is
possible to argue that Group 2 patients received a “better”
surgery and therefore were less likely to develop SAM/
LVOTO after repair; however, more posterior leaflet was,
on average, resected in Group 1. Although there is probably
some variation on the surgical repair, we feel that the
prerepair data can identify a group of patients at risk for
SAM/LVOTO and should be used to guide the surgical
procedure.
Three-dimensional imaging may help further clarify the
anatomy and role of the mitral valve in SAM/LVOTO.
While three-dimensional analysis is well described in the
literature, it is unavailable in most clinical settings. In
contrast, the echocardiographic image described in this
article is easily obtained.
The data collection did not include the intraoperative
anesthetic record, i.e., our data did not include pulmonary
artery pressures nor pulmonary capillary wedge pressures.
This may have been helpful in the assessment of ventricular
filling. It was our feeling that the measurement of LVIDs at
the base of the ventricle would be the best assessment of
cavitary dimensions that would contribute to SAM/
LVOTO. Furthermore, there was no significant difference
between the LVIDs between Groups 1 and 2. In addition,
the decrease in LVIDs was greater for Group 2 than Group
2, making Group 2 more likely to have had SAM. However,
this was not the case.
Conclusions. These results suggest that TEE analysis of
the mitral apparatus can identify patients likely to develop
SAM/LVOTO after mitral valve repair for myxomatous
valve disease. The AL/PL ratio was significantly lower
among patients who developed SAM/LVOTO than among
those who did not. Further, the ranges of AL/PL ratios
observed in the two groups of patients did not overlap, and
there was minimal overlap of the corresponding 95% toler-
ance intervals, suggesting that the measurement may differ-
entiate these two patient groups. Resolution was associated
with shift of the coaptation point away from the left
ventricular outflow tract and a greater contribution of the
anterior leaflet to valve closure. Thus, our data suggest the
need for a greater reduction in the posterior leaflet height if
the prerepair AL/PL ratio is 1.3 or lower. The importance
of this value may be greater if the C-Sept distance is 2.5 cm
or less. These findings are consistent with the concept that
SAM is due to anterior malposition of slack mitral leaflet
portions into the left ventricular outflow tract. The position
of the coaptation point of the mitral leaflets is dynamic and
offers a target for surgical techniques to prevent SAM with
LVOTO after mitral valve repair.
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